| Database ID | Agent | Target | Cancer Type | Detail |
| DB00736 | eribulin mesylate and erlotinib | NA | non small cell lung cancer | view |
| DB00737 | gefitinib | Epidermal growth factor receptor | lung cancer | view |
| DB00738 | afatinib | Receptor proteintyrosine kinase erbB2
Epidermal growth factor receptor | lung cancer | view |
| DB00739 | gefitinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00740 | gefitinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00741 | motesanib | Mast/stem cell growth factor receptor
Plateletderived growth factor receptor
Vascular endothelial growth factor receptor 2 | non small cell lung cancer | view |
| DB00742 | erlotinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00743 | gefitinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00744 | erlotinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00745 | Erlotinib plus bevacizumab | NA | non small cell lung cancer | view |
| DB00746 | erlotinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00747 | gefitinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00748 | gefitinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00749 | gefitinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00750 | gefitinib | Epidermal growth factor receptor | non small cell lung cancer | view |